31 West 52nd Street,16th Floor
New York , NY, 10019
New York , NY, 10019
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in the component securities of More
Webiste
Directors
Jan 16, 2024- Robert S. Tull, Jr.
- William J. Smalley
- Myles J. Edwards
- James A. Simpson
Chief Compliance Officer
- Timothy Branigan
Price
- $ 53.37 ( -5.8 )
-
Apr 04, 2025Last Close
- Net Assets
-
$17.2M
Mar 28, 2024
- 52-Week High/Low
- $68.1 - $50.6
- Expense Ratio
- -
Performance
YTD
0%
3 Year
17.14%
5 Year
45.69%
Best
145.29%
2004
Worst
-89.06%
2014
Company Name |
Holding |
| DREYFUS GOVERNMENT CASH MANAGE | 2.56 % |
| Mirum Pharmaceuticals Inc | 2.28 % |
| Alnylam Pharmaceuticals Inc | 2.22 % |
| Kiniksa Pharmaceuticals Intern | 2.12 % |
| LIGAND PHARMACEUTICALS | 2.01 % |
| Travere Therapeutics Inc | 1.97 % |
| Legend Biotech Corp | 1.93 % |
| ACADIA Pharmaceuticals Inc | 1.89 % |
| Lexicon Pharmaceuticals Inc | 1.84 % |
| Axsome Therapeutics Inc | 1.8 % |
| More | 1.8 % |
Documents
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BBP | 0% | -3.4% | 17.9% | 0.9% | -8.2% | 22.2% | 24.7% | -14% | 24.1% | 6.3% | |
| S&P 500 | -13.7% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | -2.6% | 0% | -11% | -1.6% | -14% | 28.4% | 1.8% | 15.3% | -20% | ||||
| q2 | 0% | -3.1% | 6.8% | -5.2% | 1.9% | 26.6% | -8.2% | 11.1% | 5.1% | 9.4% | ||||
| q3 | 0% | 0% | -4.9% | 10% | -4.6% | 0.5% | -11.6% | 3.3% | 4.8% | 23.7% | ||||
| q4 | 0% | 0% | 18.9% | 8.7% | -4% | 11.6% | 20.6% | -22.5% | -4% | -1.8% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | -1.2% | 4% | -5.2% | -6.4% | 5.9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |